Nathalie Lvoff

Nathalie Lvoff has a strong background in marketing and public policy, particularly in the healthcare industry. Nathalie has held various roles throughout their career, starting as a Product Manager at Laboratoire Roche Nicholas. Nathalie then went on to work as a Senior Product Manager at Takeda, where they led the national launch of a new oral antidiabetic drug. Lvoff later joined GSK as a Senior Product Manager, focusing on strategic and operational marketing of HIV drugs. Nathalie also led important projects, such as the launch of a genetic test and the implementation of a point-of-care electronic medical record system for HIV-infected patients.

Lvoff then joined ViiV Healthcare as a Marketing Director, where they were responsible for access to treatments and partnerships. Nathalie played a key role in the Pricing and Reimbursement process of Tivicay and Triumeq. Nathalie also served on the executive board, offering strategic solutions and participating in decision making within the company.

In 2017, Lvoff gained experience as an Active Observer at both Institut Français du sein and Gustave Roussy, where they focused on observing patient consultations and shadowing consultant specialists in various oncology fields.

Nathalie then joined TESARO, Inc. as a Consultant, where they prepared and launched two major products: Varuby for CINV and Zejula for OC. Nathalie developed successful marketing strategies for the pre-launch and full product launch stages.

Most recently, Lvoff joined Clovis Oncology as the Public Policy, Communication, and Market Access Director for France and Benelux. Here, they sit on the executive board and leads the assessment and reimbursement processes for Rubraca. Nathalie has also been involved in referencing Rubraca with hospital groups.

Throughout their career, Lvoff has demonstrated strong leadership and strategic thinking skills, as well as the ability to develop successful marketing and market access plans.

Nathalie Lvoff's education history includes earning a Masters Degree in Intelligence Marketing from HEC Paris in 1996. Prior to that, they pursued an industry concentration and completed their doctoral thesis in Pharmacy with an emphasis on the pharmaceutical industry at Faculté de Pharmacie, Paris XI from 1990 to 1996. In 2017 and 2023, they attended the Institut Gustave Roussy - Ecole des sciences du cancer for specialized medical treatment courses in chemotherapy and cancer. The specific field of study for these courses is not provided in the given information. Additionally, Nathalie Lvoff has also studied at the Faculté de Pharmacie Paris XI, HEC, Ecole des sciences du cancer (Institut Gustave Roussy), but the details of their degree and field of study are unspecified.